Patent · US Active

Oligonucleotide compositions and methods thereof

US11634710B2 · kind B2 · utility

4Cited by
51References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 2020
Grant dateApr 25, 2023
Priority date
Expiry dateAug 25, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/346
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Among other things, the present disclosure relates to designed oligonucleotides, compositions, and methods thereof. In some embodiments, provided oligonucleotide compositions provide altered splicing of a transcript. In some embodiments, provided oligonucleotide compositions have low toxicity. In some embodiments, provided oligonucleotide compositions provide improved protein binding profiles. In some embodiments, provided oligonucleotide compositions have improved delivery. In some embodiments, provided oligonucleotide compositions have improved uptake. In some embodiments, the present disclosure provides methods for treatment of diseases using provided oligonucleotide compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.